5441 news items
Page 7 of 100
5kg9hxceiv2a861kqv2179lsp3ptc lvd
BSX
18 May 24
– Risk Factors in Quarterly Reports on Form 10-Q we have filed or will file hereafter. We disclaim any intention or obligation to publicly update
n2wpp521484x0vc2srtrxl ckx50o2uv0z74ur9w1fmdoy2
GILD
18 May 24
in detail in Gilead's Quarterly Report on Form 10-Q for the quarter ended March 31, 2024, as filed with the U.S. Securities and Exchange Commission
c9t591o wv5a5r2
FFIE
18 May 24
10-Q for the quarter ended September 30, 2023, as well as the risk factors incorporated by reference in Item 8.01 of the Current Report on Form 8-K
jqe1f0cxt2j3h44ccfhncx1qpew7j31kf38pjxnttn7qld2jrvki3dj
MASI
18 May 24
: On May 7, 2024, after market hours, Masimo filed its quarterly report on Form 10-Q with Securities and Exchange Commission ("SEC
fk0ej6vnhuhm40t4mwi1z51q4m cbwmzc7
MASI
17 May 24
market hours, Masimo filed its quarterly report on Form 10-Q with Securities and Exchange Commission ("SEC") which, among other things, announced
9855kwz
ADSK
17 May 24
The Class Period begins on June 1, 2023, when Autodesk filed with the SEC its quarterly report on Form 10-Q for the period ended April 30, 2023. Therein
4di b3rz100oflo4
IOVA
17 May 24
on Form 10-Q, and include, but are not limited to, the following substantial known and unknown risks and uncertainties inherent in our business
k3qiv640sm77horlmvdn rnsy7h8jkmve96g0v3s9v2
MAPS
17 May 24
of the Company's failure to timely file its Quarterly Report on Form 10-Q for the quarter ended March 31, 2024 ("Quarterly Report") and its continued delay
349a7dsg891 psp92yu80vrhdxlo47i6dadtfsl8v9ytjb
AZEK
17 May 24
Company Manual as a result of its failure to timely file its Quarterly Report on Form 10-Q for the fiscal quarter ended March 31, 2024 (the "Form 10-Q
g6on634jh8i0lpvduyit8qhegj9lig0lff0kkr4 7hd3p0vhe41le2s0sg
AULT
17 May 24
Commission, including, but not limited to, the Company's Forms 10-K, 10-Q and 8- K. All filings are available
xs8gd7kth6r3p9bboq1jr71nl ty1bzhsoad5v2w7cp3hp
AZEK
17 May 24
to timely file its Quarterly Report on Form 10-Q for the fiscal quarter ended March 31, 2024 (the "Form 10-Q") with the Securities and Exchange Commission
5gjid9v195gs9nge56y bx7jcmbccta8wv9bhzlcez
DBVT
17 May 24
in DBV's Quarterly Report on Form 10-Q for the quarter ended March 31, 2024, filed with the SEC on May 7, 2024, and future filings and reports made
omooss3r 3t
DZSI
17 May 24
listing requirements under Nasdaq Listing Rule 5250(c)(1) (the "Rule") because the Company did not timely file its Quarterly Report on Form 10-Q
ywdwk82wcix zebyz66ognbw
17 May 24
& Johnson's subsequent Quarterly Reports on Form 10-Q and other filings with the Securities and Exchange Commission. Copies of these filings
z7q4iygvgl19wk4lrioe0eznh7ulmcroriqqm2gfkz3tfgu b6kpsvq
SOND
17 May 24
Rule") as a result of its failure to timely file its Quarterly Report on Form 10-Q for the quarter ended March 31, 2024 (the "Q1 2024 Form 10-Q
ltmeziq3ckeajwfo53w59j2zi9m6fpg2pg761lqrviu4238x
TTOO
17 May 24
filings the Company makes with the SEC from time to time, including our Quarterly Reports on Form 10-Q and Current Reports on Form 8-K. These and other
6u8231lvj
MESA
17 May 24
Quarterly Report on Form 10-Q for the period ended March 31, 2024 (the "Form 10-Q") with the Securities and Exchange Commission. The filing delay
hbw8sjtkp ve67j45obmmgx6ahsyvrzbe8004d
ALPP
17 May 24
the Company has not filed its Quarterly Report on Form 10-Q for the period ended September 30, 2023 (the "Quarterly Report"), or its Annual Report
yr30034jtim90xpew03bcou514c iwuqvp72ra9htux
SHLS
17 May 24
Quarterly Report on Form 10-Q for the third quarter of 2023 ("2Q23 10-Q") and held an accompanying earnings call in which Defendants revealed that the wire
yzlxf8g7f1n1ubqhvgm2b3 2rg5vm0fb8lic24
17 May 24
.
With chronic kidney disease (CKD) affecting about 1 in 10 adults worldwide, new therapeutics have been